{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:53:50Z","timestamp":1792788830284,"version":"4.5.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["U54EB027049"],"award-info":[{"award-number":["U54EB027049"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["U54EB007958"],"award-info":[{"award-number":["U54EB007958"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068613"],"award-info":[{"award-number":["UM1AI068613"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["U54EB027049"],"award-info":[{"award-number":["U54EB027049"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"name":"US National Institutes of Health","id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This study aimed to assess global stakeholder preferences for key attributes of point-of-care (POC) HIV Nucleic Acid Amplification Tests (NAAT), with the aim of informing product development to support progress toward UNAIDS 95-95-95 targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A web-based conjoint survey was conducted in August through November 2024 among HIV clinicians, laboratory professionals, and researchers. Participants were asked to evaluate hypothetical POC HIV NAAT profiles varying by six attributes: sensitivity \/ limit of detection (LOD), sample-collection method, turnaround time (TAT), result format, price, and power source. Relative importance and part-worth utilities were calculated to assess trade-offs in decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred three respondents from 33 countries, primarily in Africa (75%), completed the survey. The relative importance placed on the attributes in the conjoint task varied based on the setting. In community and home-based settings, participants prioritized fingerstick sample collection (25.90%) and faster TATs (28.8%), even at the expense of sensitivity (15.70%). By contrast, respondents from hospitals and health centers valued tests with high sensitivity (42.6%, 40.9%) and faster TATs (31.5%, 22.6%). Across all respondents, price (7.0%), result format (3.30%), and power source (7.25%) were less influential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Stakeholders were willing to make trade-offs among desirable attributes, prioritizing rapid turnaround time, strong sensitivity, and fingerstick sampling over affordability, power requirements, and result format in the conjoint task. These preferences vary by level of care and by use case, underscoring the importance of aligning product features with contextual needs. Engaging stakeholders early in the design process is critical to ensure new POC HIV NAAT technologies are both acceptable and scalable in low-resource settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0361025","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:27:11Z","timestamp":1792690031000},"page":"e0361025","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global stakeholder preferences for point-of-care HIV nucleic acid amplification tests: A conjoint study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8055-9706","authenticated-orcid":true,"given":"Kara M.","family":"Palamountain","sequence":"first","affiliation":[{"name":"Northwestern University","place":["Evanston, Illinois, United States of America"],"department":["Kellogg School of Management"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chethana","family":"Achar","sequence":"additional","affiliation":[{"name":"Northwestern University","place":["Evanston, Illinois, United States of America"],"department":["Kellogg School of Management"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8724-7871","authenticated-orcid":true,"given":"Rebecca P.","family":"Kirby","sequence":"additional","affiliation":[{"name":"Northwestern University","place":["Evanston, Illinois, United States of America"],"department":["Kellogg School of Management"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari C.","family":"Manabe","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine","place":["Baltimore, Maryland, United States of America"],"department":["Division of Infectious Diseases, Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debi","family":"Boeras","sequence":"additional","affiliation":[{"name":"Global Health Impact Group","place":["Atlanta, Georgia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7436-426X","authenticated-orcid":true,"given":"Michal","family":"Maimaran","sequence":"additional","affiliation":[{"name":"Northwestern University","place":["Evanston, Illinois, United States of America"],"department":["Kellogg School of Management"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"pone.0361025.ref001","unstructured":"Global HIV Programme. [cited 2025 May 31]. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics"},{"key":"pone.0361025.ref002","volume-title":"HIV and AIDS: technical work [Internet]","author":"World Health Organization"},{"key":"pone.0361025.ref003","doi-asserted-by":"crossref","first-page":"1565242","DOI":"10.3389\/fpubh.2025.1565242","article-title":"Considerable variation in the 95-95-95 targets accomplishment between children and adults might delay achievement of set targets","volume":"13","author":"BW Kulohoma","year":"2025","journal-title":"Front Public Health"},{"key":"pone.0361025.ref004","unstructured":"Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV. [cited 2025 May 31]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240077089"},{"key":"pone.0361025.ref005","unstructured":"Recent HIV RDT market landscape report aims for healthier, more sustainable markets. [cited 2025 May 31]. Available from: https:\/\/www.who.int\/news\/item\/13-07-2023-hiv-rdt-market-report-aims-for-healthier-more-sustainable-markets"},{"key":"pone.0361025.ref006","unstructured":"Clinical Guidance for PrEP | HIV Nexus | CDC. [cited 2025 May 31]. Available from: https:\/\/www.cdc.gov\/hivnexus\/hcp\/prep\/index.html"},{"key":"pone.0361025.ref007","doi-asserted-by":"crossref","first-page":"107222","DOI":"10.1016\/j.ijid.2024.107222","article-title":"Suppressed HIV antibody responses following exposure to antiretrovirals-evidence from PrEP randomized trials and early antiretroviral treatment initiation studies","volume":"148","author":"VI Avelino-Silva","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"4","key":"pone.0361025.ref008","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/COH.0000000000000746","article-title":"How could HIV-1 drug resistance impact pre-exposure prophylaxis for HIV prevention?","volume":"17","author":"UM Parikh","year":"2022","journal-title":"Curr Opin HIV AIDS"},{"key":"pone.0361025.ref009","unstructured":"What\u2019s New: Adult and Adolescent ARV HIV Clinical Guidelines | NIH. [cited 2025 May 31]. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/whats-new?guideline%5B0%5D=title_bookpart%3AHIV+Clinical+Guidelines%3A+Adult+and+Adolescent+ARV&redirected=1"},{"issue":"28","key":"pone.0361025.ref010","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003985","article-title":"Should viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settings","volume":"95","author":"ND Labhardt","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"pone.0361025.ref011","unstructured":"The role of HIV viral suppression in improving individual health and reducing transmission. [cited 2025 May 31]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240055179?utm_source=chatgpt.com"},{"issue":"3","key":"pone.0361025.ref012","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00097-18","article-title":"Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV\/AIDS Response","volume":"32","author":"PK Drain","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"10400","key":"pone.0361025.ref013","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(23)00877-2","article-title":"The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: A systematic review","volume":"402","author":"LN Broyles","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"pone.0361025.ref014","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrmicro841","article-title":"Diagnostics for the developing world","volume":"2","author":"D Mabey","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"pone.0361025.ref015","unstructured":"Kettler H, White K, Hawkes S. Mapping the landscape of diagnostics for sexually transmitted infections: Key findings and recommendations. [cited 2025 May 31]. Available from: https:\/\/iris.who.int\/handle\/10665\/68990"},{"issue":"1","key":"pone.0361025.ref016","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41564-018-0295-3","article-title":"REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes","volume":"4","author":"KJ Land","year":"2019","journal-title":"Nat Microbiol"},{"key":"pone.0361025.ref017","unstructured":"The International Diagnostics Centre, London School of Hygiene and Tropical Medicine. Target product profile: Point-of-care HIV viral load test. 2013. http:\/\/www.idc-dx.org\/resources\/target-product-profile-point-of-care-hiv-viral-load-test"},{"key":"pone.0361025.ref018","unstructured":"Advanced Platforms for HIV Viral Load Monitoring - CIMIT MAIN - GAITS. [cited 2025 May 31]. Available from: https:\/\/www.cimit.org\/-\/advanced-platforms-for-hiv-viral-load-monitoring?utm_source=CIMIT&utm_campaign=HIVII2024launch&utm_medium=email"},{"issue":"6","key":"pone.0361025.ref019","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/1475-6773.01115","article-title":"Measuring preferences for health care interventions using conjoint analysis: An application to HIV testing","volume":"37","author":"KA Phillips","year":"2002","journal-title":"Health Serv Res"},{"issue":"4","key":"pone.0361025.ref020","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s10461-019-02701-7","article-title":"A conjoint analysis of the acceptability of targeted long-acting injectable antiretroviral therapy among persons living with HIV in the U.S","volume":"24","author":"JM Simoni","year":"2020","journal-title":"AIDS Behav"},{"issue":"4","key":"pone.0361025.ref021","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1089\/aid.2021.0075","article-title":"Conjoint analysis of user acceptability of sustained long-acting pre-exposure prophylaxis for HIV","volume":"38","author":"RJ Schieffer","year":"2022","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0361025.ref022","article-title":"Thirty years of conjoint analysis: Reflections and prospects","volume":"31","author":"P Green","year":"2001","journal-title":"Interfaces"},{"key":"pone.0361025.ref023","unstructured":"Wheeler RE. AlgDesign: algorithmic experimental design. 2022."},{"key":"pone.0361025.ref024","first-page":"239","article-title":"Conjoint analysis method and its implementation in conjoint R package.","volume-title":"Data analysis methods and its applications","author":"A Bak","year":"2012"},{"key":"pone.0361025.ref025","unstructured":"R Core Team. R: A language and environment for statistical computing [Internet]. Vienna: R Foundation for Statistical Computing; 2024 [cited 2026 Jul 21]. Available from: https:\/\/www.R-project.org\/"},{"issue":"4","key":"pone.0361025.ref026","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40572-020-00295-0","article-title":"Power Outages and Community Health: A Narrative Review","volume":"7","author":"JA Casey","year":"2020","journal-title":"Curr Environ Health Rep"},{"issue":"1","key":"pone.0361025.ref027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/diagnostics7010003","article-title":"Implementation of point-of-care diagnostics in rural primary healthcare clinics in South Africa: perspectives of key stakeholders","volume":"7","author":"T Mashamba-Thompson","year":"2017","journal-title":"Diagnostics"},{"issue":"4","key":"pone.0361025.ref028","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042944","article-title":"Qualitative analysis of stakeholder interviews to identify the barriers and facilitators to the adoption of point-of-care diagnostic tests in the UK","volume":"11","author":"JR Huddy","year":"2021","journal-title":"BMJ Open"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0361025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:27:17Z","timestamp":1792690037000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0361025"}},"subtitle":[],"editor":[{"given":"Elain","family":"Fu","sequence":"first","affiliation":[{"name":"Oregon State University","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0361025","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]}}}